C0003241||antibody
C1437495||endosialin
C1437495||Tumor Endothelial Marker-1
C1437495||Endosialin (Tumor Endothelial Marker-1 (TEM-1), CD248)
C0598800||pericytes
C0027651||tumor
C0243079||microvasculature
C0027651||tumor
C0162597||stromal cells
C0027651||tumors
C1257975||mesenchymal origin
C1261473||sarcoma
C0025202||melanoma
C1437495||endosialin/TEM-1
C2603343||studies
C1269955||invasion
C0006826||cancer
C2985546||humanized
C1437495||anti-endosialin/TEM-1
C0003250||monoclonal antibody
C0003250||monoclonal antibody
C2826153||ontuxizumab
C2826153||MORAb-004
C1709631||preclinical
C0008972||clinical studies
C0034861||recombinant
C1437495||endosialin/TEM-1 protein
C1517050||extracellular domain
C1517050||extracellular domain
C0030935||fragments
C0003250||mAbs
C1517050||extracellular domain
C1514562||motifs
C1149343||domain-specific
C0003316||epitopes
C1517050||extracellular domain
C0442726||detect
C0678594||structural
C1514562||motifs
C1704656||diagnostic
C0003250||mAbS
C0541850||cross-react
C0591833||murine
C0086418||human
C0033684||protein
C0086418||human
C0599779||animal models
C0008976||clinical trials
C0003250||mAbs
C0523404||immunoassays
C1749467||soluble
C1437495||endosialin/TEM-1
C1437495||soluble endosialin/TEM-1
C0229671||serum
C1708335||healthy subjects